Skip to main content

and
  1. Article

    Open Access

    Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters

    Since the beginning of the COVID-19 pandemic, several variants of concern (VOC) have emerged for which there is evidence of an increase in transmissibility, more severe disease, and/or reduced vaccine effectiv...

    Catherine Berry, Vincent Pavot, Natalie G. Anosova in Communications Medicine (2023)

  2. Article

    Open Access

    TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

    Globally rifampicin-resistant tuberculosis disease affects around 460,000 people each year. Currently recommended regimens are 9–24 months duration, have poor efficacy and carry significant toxicity. A shorter...

    Catherine Berry, Philipp du Cros, Katherine Fielding, Suzanne Gajewski in Trials (2022)